Virtu KCG Holdings’s Anavex Life Sciences AVXL Stock Holding History

Virtu KCG Holdings’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$186K	Buy	+34,977	New	+$202K	0.01%	2190
2017 Q1	–	Sell	-12,164	Closed	-$48K	–	3114
2016 Q4	$48K	Sell	12,164 -13,236	-52%	-$47.2K	﹤0.01%	3092
2016 Q3	$92K	Buy	25,400 +10,482	+70%	+$44.1K	﹤0.01%	2654
2016 Q2	$91K	Buy	+14,918	New	+$72.1K	﹤0.01%	2558
2016 Q1	–	Sell	-61,933	Closed	-$345K	–	2782
2015 Q4	$345K	Buy	+61,933	New	+$441K	0.01%	1980

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Virtu KCG Holdings's AVXL Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Anavex Life Sciences (AVXL) in Q2 2017: 34,977 shares worth $186K. The stake represents 0.01% of the portfolio and ranks #2190 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in AVXL as recently as Q4 2016.

Virtu KCG Holdings first reported a position in AVXL in Q4 2015 and has held it in 5 quarters since. The position peaked at $345K in Q4 2015. 61 funds tracked by Wall St. Rank hold AVXL as of Q2 2017.

Virtu KCG Holdings held 34,977 shares of Anavex Life Sciences worth $186K as of Q2 2017.
Anavex Life Sciences was a new Virtu KCG Holdings position in Q2 2017.
Anavex Life Sciences made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2190 holding.
Virtu KCG Holdings first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 5 quarters since.
Virtu KCG Holdings's Anavex Life Sciences position peaked at $345K in Q4 2015.
61 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.